751 related articles for article (PubMed ID: 33087032)
41. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line.
Arulnathan SB; Leong KH; Ariffin A; Kareem HS; Cheah KKH
Anticancer Agents Med Chem; 2020; 20(9):1072-1086. PubMed ID: 32188392
[TBL] [Abstract][Full Text] [Related]
42. Cytotoxicity,
Tantawy MA; Shaheen S; Kattan SW; Alelwani W; Barnawi IO; Elmgeed GA; Nafie MS
J Biomol Struct Dyn; 2022 Jul; 40(10):4352-4365. PubMed ID: 33300466
[TBL] [Abstract][Full Text] [Related]
43. Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis.
Ibrar A; Zaib S; Jabeen F; Iqbal J; Saeed A
Arch Pharm (Weinheim); 2016 Jul; 349(7):553-65. PubMed ID: 27214743
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, ADMET predictions, molecular docking studies, and
Sulistyowaty MI; Widyowati R; Putra GS; Budiati T; Matsunami K
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):385-392. PubMed ID: 34214332
[TBL] [Abstract][Full Text] [Related]
45. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
Goud NS; Ghouse MS; Vishnu J; Pranay J; Alvala R; Talla V; Qureshi IA; Alvala M
Anticancer Agents Med Chem; 2019; 19(4):557-566. PubMed ID: 30734685
[TBL] [Abstract][Full Text] [Related]
47. p53-independent structure-activity relationships of 3-ring mesogenic compounds' activity as cytotoxic effects against human non-small cell lung cancer lines.
Fukushi S; Yoshino H; Yoshizawa A; Kashiwakura I
BMC Cancer; 2016 Jul; 16():521. PubMed ID: 27456853
[TBL] [Abstract][Full Text] [Related]
48. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
49. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
50. Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis,
Sridhar Goud N; Pooladanda V; Muni Chandra K; Lakshmi Soukya PS; Alvala R; Kumar P; Nagaraj C; Dawn Bharath R; Qureshi IA; Godugu C; Alvala M
Bioorg Chem; 2020 Sep; 102():104125. PubMed ID: 32738568
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
52. Development of certain aminoquinazoline scaffolds as potential multitarget anticancer agents with apoptotic and anti-proliferative effects: Design, synthesis and biological evaluation.
Amin NH; El-Saadi MT; Abdel-Fattah MM; Mohammed AA; Said EG
Bioorg Chem; 2023 Jun; 135():106496. PubMed ID: 36989735
[TBL] [Abstract][Full Text] [Related]
53. Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking.
Krstulović L; Leventić M; Rastija V; Starčević K; Jirouš M; Janić I; Karnaš M; Lasić K; Bajić M; Glavaš-Obrovac L
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677600
[TBL] [Abstract][Full Text] [Related]
54. Cytotoxic Evaluation and Molecular Docking Studies of Aminopyridine Derivatives as Potential Anticancer Agents.
Ilyas U; Alkury LT; Naaz S; Muhammad SA; Nadeem H; Altaf R; Zaman SU; Faheem M; Sajid I; Cheema MT; Mannan A; Shah FA; Li S
Anticancer Agents Med Chem; 2022; 22(14):2599-2606. PubMed ID: 34963435
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors.
Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2020 May; 353(5):e2000008. PubMed ID: 32159244
[TBL] [Abstract][Full Text] [Related]
56. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR
Gaber AA; Bayoumi AH; El-Morsy AM; Sherbiny FF; Mehany ABM; Eissa IH
Bioorg Chem; 2018 Oct; 80():375-395. PubMed ID: 29986185
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
59. Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway.
Wang WJ; Mao LF; Lai HL; Wang YW; Jiang ZB; Li W; Huang JM; Xie YJ; Xu C; Liu P; Li YM; Leung ELH; Yao XJ
Pharmacol Res; 2020 Nov; 161():105129. PubMed ID: 32783976
[TBL] [Abstract][Full Text] [Related]
60. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
